Shared on04 Aug 25Fair value Increased 7.95%
Medacta Group's higher consensus price target reflects improved sentiment driven by a modest increase in net profit margin and a slight decrease in the future P/E ratio, raising fair value estimates from CHF145.35 to CHF153.91. What's in the News Medacta Group will hold its H1 2025 Sales/Trading Statement Call on July 31, 2025.
Shared on23 Apr 25Fair value Decreased 1.67%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Increased 0.45%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Increased 2.75%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 3.26%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Decreased 6.21%
AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.
Shared on19 Mar 25Fair value Increased 0.82%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Increased 4.33%
AnalystConsensusTarget has increased revenue growth from 13.2% to 14.6% and increased shares outstanding growth rate from -0.0% to 0.0%.